Active
Small Business
Overview
- Legal name
- COCRYSTAL PHARMA, INC.
- Registered location
- BOTHELL, WA, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Sep 29, 2025
Read company summary
COCRYSTAL PHARMA, INC. is associated with UEI UY8UDESGRJ17 and CAGE 7SGF5 in public federal records. AcornBids currently links 1 prime award totaling $498.2K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists BOTHELL, WA, USA.
At a glance
Lifetime prime obligations$498.2K
Prime awards1
Awards with future end dates1
Top-agency concentration100.0%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- COCRYSTAL PHARMA, INC.
- UEI
- UY8UDESGRJ17
- CAGE
- 7SGF5
- Registered address
- 19805 N CREEK PKWY STE 100, BOTHELL, WA, 98011, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Dec 15, 2025
- Initial registration
- Aug 31, 2023
- Entity start
- Jan 4, 2014
- SAM updated
- Dec 15, 2025
- Registration expires
- Dec 11, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93025C00038DEVELOPMENT OF PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX | Department of Health and Human Services | $498.2K | Sep 29, 2025 | Sep 29, 2026 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 15, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Aug 31, 2023 |
| Entity start | Jan 4, 2014 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| SAM LEE | Government business | Contact method not published | SAM registration | Not available |
| MARIE CROUCH | Alternate government business | Contact method not published | SAM registration | Not available |
| SAM LEE | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
158 awards
77 awards
70 awards
58 awards
54 awards
41 awards
25 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit